In the context of cancer research, evidence has emerged only in the last five years, with reports pointing to FOXK2 as a transcription factor with either oncogenic and tumour suppressing functions, as summarized in Table 2 and Table 3. The gene discussed is FOXK2; the disease is neoplasm.